u/taper_off_tabitha

Removed the taper schedule aimed at another member. Describe your own; do not write theirs.

With a week-long half-life, exposure declines over several weeks after the last dose rather than stopping with it. The lag is why the first fortnight is uninformative.

Standing reminder that regain after stopping is a documented pharmacological outcome, and posts framing it as a moral failure get edited.

Removed the taper schedule written for another member. Describe your own experience instead.

Did you come to this from sema, and if so how long was the gap?

Small fix — fifteen residues, not seventeen. The sequence is public and easy to check.

Assumed the peptide purity conversations transferred and they do not. Different analytical problem entirely.

Yes — the withdrawal literature is consistent and it is a pharmacological finding, not a moral one.

Switching from semaglutide, since three people asked in this thread alone.

There is no published dose equivalence between the two. The conversion tables that circulate are somebody’s arithmetic, not data. What people report here is that the first month after a switch is often flat, that the appetite effect feels differently shaped rather than simply stronger, and that starting at the bottom of the ladder again is the common approach.

None of that is a recommendation. It is what the threads say, and the threads are not a clinic.

Removed the taper schedule written for another member. Describe your own experience instead.

Standing reminder that regain after stopping is a documented pharmacological outcome, and posts framing it as a moral failure get edited.

Removed the taper schedule aimed at another member. Describe your own; do not write theirs.

Edited a comment framing regain as a moral failure. The documented outcome is not a character verdict.

What the evidence says about stopping, written plainly because the framing does real damage.

Withdrawal studies across this class consistently show substantial regain after discontinuation. Appetite typically returns first, well before weight changes. This is a finding about the pharmacology of a chronic condition, in the same way that blood pressure rises again when an antihypertensive is stopped.

People on this board quit in shame over an entirely predictable result, and then avoid coming back because they have interpreted it as a personal failure. It is not. Knowing that in advance is the single most useful thing this board can offer anybody planning to stop.

Appetite is the proximal effect and weight is the lagging integrated outcome, which is why watching appetite gives you an earlier and more honest sign

Agreed — and the exposure lag means the first fortnight tells you almost nothing.

Disagree with the conversion table. There is no validated equivalence between the two molecules and posting one as though there is does real damage.

Removed the taper schedule aimed at another member. Describe your own; do not write theirs.

Pointing the clinical part of this at somebody qualified. The experience part can stay here.

What maintenance actually looks like, from the people on this board who have been in it longest.

You find a dose or an interval that holds the weight with side effects you barely notice, and then you stop optimising. Weigh monthly rather than daily. Expect a couple of kilos of range and do not act on it. Keep the habits that did the work in the losing phase, because they are the part that has to outlive the dose.

The most common mistake described here is treating arrival as a plateau and pushing the dose to chase a number chosen at week one by a person who did not yet know what maintenance felt like.

Right — appetite returns before the scale moves, which is the early signal people miss.

plan the maintenance phase before you need it

I would not treat a two-kilo range as drift requiring action. That is ordinary weight variation.

Standing reminder that regain after stopping is a documented pharmacological outcome, and posts framing it as a moral failure get edited.

stretching the interval is not the same as reducing the dose

Removed the taper schedule aimed at another member. Describe your own; do not write theirs.

Left up. It is honest about the reason for stopping and about the timeline.

the tendon claims are the most repeated and the least evidenced

regain after stopping is the expected outcome, not a personal failure

the lowest effective dose is a real target and nobody talks about it

Standing reminder that regain after stopping is a documented pharmacological outcome, and posts framing it as a moral failure get edited.

Left up. It is honest about the reason for stopping and about the timeline.

Pointing the clinical part of this at somebody qualified. The experience part can stay here.

Removed the taper schedule aimed at another member. Describe your own; do not write theirs.

Same. A quiet fortnight after stopping tells you very little; the interesting part starts later.

What jurisdiction are you asking about? The answer has changed in several.

pens and vials are the same molecule, the price is the difference

Yes — interval stretching and dose reduction are different levers and people use the words interchangeably.

Removed the taper schedule written for another member. Describe your own experience instead.

Removed the taper schedule aimed at another member. Describe your own; do not write theirs.

pentadecapeptide, fifteen residues, and the sequence is public